OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

The mediating role of psychological flexibility in the relationship between psychotic symptom severity and depression in individuals diagnosed with schizophrenia
Erman Yıldız, Özlem Yıldırım
Journal of Psychiatric and Mental Health Nursing (2024) Vol. 31, Iss. 5, pp. 869-882
Open Access | Times Cited: 5

Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia
Pengxiang Li, Zhi Geng, Carmela Benson, et al.
Advances in Therapy (2025) Vol. 42, Iss. 2, pp. 1251-1264
Open Access

Psychopathology trajectories and relapse in first episode schizophrenia with assured long-acting injectable adherence over 24 months
Smit Retha, Luckhoff Hilmar, Phahladira Lebogang, et al.
Schizophrenia Research (2025) Vol. 276, pp. 8-14
Open Access

All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Clàudia Aymerich, Gonzalo Salazar de Pablo, Malein Pacho, et al.
Molecular Psychiatry (2024) Vol. 30, Iss. 1, pp. 263-271
Open Access | Times Cited: 2

Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective
David J. Williamson, Keith H. Nuechterlein, Todd A. Tishler, et al.
Schizophrenia Research Cognition (2022) Vol. 30, pp. 100270-100270
Open Access | Times Cited: 3

Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Anirban Basu, Carmela Benson, Ibrahim Turkoz, et al.
Journal of Managed Care & Specialty Pharmacy (2022) Vol. 28, Iss. 10, pp. 1086-1095
Open Access | Times Cited: 3

Real-world calibration and transportability of the Disease Recovery Evaluation and Modification (DREaM) randomized clinical trial in adult Medicaid beneficiaries with recent-onset schizophrenia
Anirban Basu, Charmi Patel, Alex Z. Fu, et al.
Journal of Managed Care & Specialty Pharmacy (2023) Vol. 29, Iss. 3, pp. 293-302
Open Access | Times Cited: 1

Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia
Oliver Lopena, Larry Alphs, Martha Sajatovic, et al.
The Journal of Clinical Psychiatry (2023) Vol. 84, Iss. 6
Open Access | Times Cited: 1

Page 1

Scroll to top